FDA Brief

Warning letters Drugs

FDA warning letter to

motionpharmacy.com

High riskIssued Sep 10, 2025Posted Sep 23, 2025Center for Drug Evaluation and Research (CDER)

FDA warns motionpharmacy.com over selling unapproved and misbranded prescription drugs online.

What happened

FDA reviewed the website www.motionpharmacy.com and found it offering opioids, benzodiazepines, Schedule II stimulants, and semaglutide for sale to U.S. consumers. FDA says these are unapproved and misbranded drugs, and that the site offers prescription drugs without a prescription.

What FDA found

  1. The website sells unapproved new drugs—products without FDA-approved applications—including opioids, benzodiazepines, stimulants, and semaglutide.

    FD&C Act §§ 301(d), 505(a) [21 U.S.C. §§ 331(d), 355(a)]
  2. The drugs are misbranded because their labeling lacks adequate directions for a layperson to use them safely.

    FD&C Act § 502(f)(1) [21 U.S.C. § 352(f)(1)]
  3. The website offers prescription drugs for sale without a prescription.

    FD&C Act § 503(b)(1) [21 U.S.C. § 353(b)(1)]
  4. FDA says the site causes misbranded drugs to be introduced into interstate commerce by offering them for sale to U.S. consumers.

    FD&C Act § 301(a) [21 U.S.C. § 331(a)]

What FDA wants

FDA requests that motionpharmacy.com stop offering any unapproved and misbranded drugs for sale to U.S. consumers. The letter does not state a response deadline.

Who should pay attention

  • online pharmacies and telehealth sellers of prescription drugs
  • platforms hosting or linking to pharmacy websites
  • clinicians and consumers who rely on legitimate prescription drugs

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk